Greenwich LifeSciences, Inc. SEC filings GLSI

Greenwich LifeSciences, Inc. has 279 filings in SEC EDGAR's recent list, going back to Jan 27, 2020. Its latest annual report, Form ARS, was filed on Oct 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Dec 18, 2025 (shareholder vote results). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Oct 26, 2026 Dec 31, 2025
10-K Annual report Jun 1, 2026 Dec 31, 2025
ARS Annual report to shareholders Nov 3, 2025 Dec 31, 2024
10-K Annual report Apr 15, 2025 Dec 31, 2024
ARS Annual report to shareholders Nov 1, 2024 Dec 31, 2023
10-K Annual report Apr 15, 2024 Dec 31, 2023
ARS Annual report to shareholders Oct 25, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K/A Amended annual report Jun 24, 2022 Dec 31, 2021
10-K Annual report Mar 21, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GLSI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Stafford, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1799788

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.